Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Assets: 2015-2025

Historic Assets for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to $214.5 million.

  • AC Immune's Assets fell 23.91% to $214.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.5 million, marking a year-over-year decrease of 23.91%. This contributed to the annual value of $214.5 million for FY2025, which is N/A change from last year.
  • Per AC Immune's latest filing, its Assets stood at $214.5 million for Q3 2025, which was up 93,263.69% from $229,770 recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Assets peaked at $252.1 billion during Q1 2021, and registered a low of $229,770 during Q2 2025.
  • For the 3-year period, AC Immune's Assets averaged around $173.7 million, with its median value being $191.7 million (2024).
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 84,512.92% in 2021, then slumped by 99.91% in 2025.
  • AC Immune's Assets (Quarterly) stood at $283.5 million in 2021, then crashed by 31.93% to $193.0 million in 2022, then rose by 6.78% to $206.1 million in 2023, then slumped by 99.87% to $263,592 in 2024, then decreased by 23.91% to $214.5 million in 2025.
  • Its Assets stands at $214.5 million for Q3 2025, versus $229,770 for Q2 2025 and $234.8 million for Q1 2025.